Biotech play PROG stock will likely continue to move wildly
After running hot for a few weeks, excitement has cooled for Progenity (NASDAQ:PROG). Less than a month ago, it was trading for as much as $6.20 per share. But since then, PROG stock has fallen by around more than 50%, and trades for around $2.50 per share today.
Speculative by their nature, clinical-stage biotech plays like this one are known for swinging wildly. This stresses the need to appropriately size positions. Not to mention, do your due diligence before taking the plunge with any specific stock in this sector.
Here’s a deeper look into the company.
The post The Long-Term Story Still Holds True for Volatile Progenity Stock appeared first on InvestorPlace.